R & d- medical: biomedical (basic research)

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201400038C
Awardee
Awarding agency
Obligated
$222,900

Award facts

Opportunity
  • N43C04100527 Solicitation number
Contract value 100% obligated
$222,900.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 27 offers Basic Research
Pricing
Firm Fixed Price
Place of performance
Potomac, MD 20854, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This federal contract award, with the ID HHSN261201400038C, was issued by the National Cancer Institute, a civilian agency, to Synergene Therapeutics Inc., a for-profit organization. The contract is for research and development in the medical and biomedical (basic research) domain, with a firm fixed price of $222,900.00 and a completion date of June 14, 2015. The contract was awarded on September 15, 2014 and did not have a set-aside designation. The contract appears to be a standalone award, not associated with a larger vehicle.

Quick answers

Who was awarded contract HHSN261201400038C?

HHSN261201400038C was awarded to Synergene Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2014.

How much is contract HHSN261201400038C worth?

The government has obligated $222,900 on HHSN261201400038C.

Was contract HHSN261201400038C competed?

The extent of competition for HHSN261201400038C was full and open competition. The government received 27 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login